Revenue: As of FY2026 Q1, the actual value is USD 396.8 M.EPS: As of FY2026 Q1, the actual value is USD 0.22.EBIT: As of FY2026 Q1, the actual value is USD 17.71 M.<h3>Research Segment</h3><ul><li>Revenue: $281.7 million for the three months ended July 31, 2025, an increase of 6% compared to the prior year.</li><li>Adjusted Operating Income: $56.2 million, an increase of 2% compared to the prior year.</li><li>Adjusted EBITDA: $79.6 million, an increase of 2% compared to the prior year.</li></ul><h3>Learning Segment</h3><ul><li>Revenue: $115.1 million for the three months ended July 31, 2025, a decrease of 7% compared to the prior year.</li><li>Adjusted Operating Income: $21.7 million, a decrease of 4% compared to the prior year.</li><li>Adjusted EBITDA: $31.5 million, a decrease of 7% compared to the prior year.</li></ul><h3>Held for Sale or Sold Segment</h3><ul><li>Revenue: $0 for the three months ended July 31, 2025, compared to $14.2 million in the prior year due to the sale of Wiley Edge and CrossKnowledge.</li><li>Adjusted EBITDA: $0 for the three months ended July 31, 2025, compared to a loss of $2.5 million in the prior year.</li></ul><h3>Corporate Expenses</h3><ul><li>Adjusted Unallocated Corporate Expenses: $43.9 million, an increase of 4% compared to the prior year.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $85.0 million for the three months ended July 31, 2025.</li><li>Free Cash Flow Less Product Development Spending: - $99.9 million for the three months ended July 31, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Global Restructuring Program: Expected to yield annualized cost savings of approximately $105 million, with substantial realization in fiscal year 2026.</li><li>Business Optimization Program: No further material charges anticipated, with immaterial ongoing facility charges expected.</li></ul>

John Wiley & Son | 10-Q: FY2026 Q1 Revenue: USD 396.8 M